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IgG4-related disease (IgG4-RD) is a recently recognized fibroinflammatory condition associ-
ated with disease in nearly every organ, including the meninges. A proportion of idiopathic
hypertrophic pachymeningitis cases may involve a component of meningeal IgG4-RD. We
present a patient with severe bilateral vision loss found to have thickening of the dura mater
on MRI, and subsequently diagnosed with IgG4-RD after dural biopsy.
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CASE
A 44-year-old man presented to the emergency department with
progressive vision loss. He reported worsening vision for 8 days to
near blindness, new-onset severe, and pressure like, non-pulsatile
headache. Past medical history was remarkable for diabetes, hyper-
tension, dyslipidemia, and rheumatoid arthritis. Vital signs were
stable and the neurological examination showed no light percep-
tion on the OS, and only hand motion perception on the OD.
Non-contrast CT of the head showed no intracranial abnor-
mality. Ophthalmological evaluation found no apparent expla-
nation for the visual loss. Dexamethasone therapy was initiated.
Contrast-enhanced MRI of the brain done 1 day later showed dif-
fuse thickening and enhancement of the dura, greater on the left
side (Figure 1A). MRI of the orbits showed bilateral enhance-
ment of the posterior aspect of the intraconal optic nerve sheath
(Figure 1B). Lumbar puncture demonstrated an opening pressure
of 32 mm H2O, glucose 90 mg/dL, protein content of 44 mg/dL,
RBC 1, and WBC 21 (80% lymphocytes, 16% monocytes, 4%
neutrophils). Gram stain, cultures, and cytology were negative.
IgG index was 1.09 (reference <0.66), and IgG was 13.3 mg/dL
(range 0.8–7.7). A left frontal dural biopsy was performed.
The patient’s vision continued to improve with steroid ther-
apy and on day 10, VA was noted to be 20/20 on the OD and
20/30 on OS. Pathological evaluation showed pachymeningitis
with increased IgG4 plasma cells (Figure 2). Given the clinical, lab-
oratory, and pathology results, a diagnosis of IgG4-related disease
(IgG4-RD) was made. Serum IgG4 drawn on the day of hospital
discharge revealed elevated levels of 182.0 (reference range 4–86).
DISCUSSION
IgG4-related disease is a recently recognized fibroinflammatory
condition first linked to autoimmune pancreatitis (AIP) in 2001
when pancreatic specimens from patients with AIP were found to
have large numbers of IgG4 positive cells (1). In 2003, Kamisawa
et al. reported extrapancreatic lesions in patients with AIP con-
taining histopathology identical to that found in the pancreas. It
was thus suggested that AIP was part of a larger systemic disease
and not just confined to the pancreas (2).
Since then, IgG4-RD has been associated with disease involv-
ing nearly every organ system including pancreas, salivary glands,
lacrimal glands, thyroid, pituitary, lungs, aorta, pericardium, liver,
biliary tree, kidneys, retroperitoneum, breast, prostate, lymph
nodes, skin, periorbital tissues, and the meninges (1–3). Tis-
sues from involved organs demonstrate similar histopathological
features of lymphoplasmacytic infiltration, many IgG4 positive
plasma cells, and fibrosis (1, 2).
The meninges may be involved either intracranially or
intraspinally with a predilection for involvement of the pachy-
meninges rather than the leptomeninges (1). The MRI findings
of thickened dura, along with characteristic histology of fibrosis
and lymphoplasmacytic infiltrates, fulfill the clinicopathological
features of hypertrophic pachymeningitis (HP), a rare fibroin-
flammatory lesion causing thickening of cranial and/or spinal dura
(4). HP may be due to infections such as tuberculosis and syphilis,
systemic autoimmune diseases, neoplasms, or may be idiopathic
(4). It is believed that a proportion of previously reported cases
of idiopathic hypertrophic pachymeningitis (IHP) actually repre-
sent IgG-RD. A recent retrospective study analyzed 10 cases of
IHP and showed evidence of IgG4-RD histopathology in 5 of
the 10 (2, 3).
IgG4-related vision loss is rare. IgG4-RD can present as non-
specific constitutional symptoms at the time of diagnosis, or
more likely as a sub-acute expanding mass, with disease confined
to a single organ for many years (1, 2). A proportion of cases
of IHP have demonstrated IgG4-RD. IHP presents with radicu-
lomyelopathy, headaches, cranial nerve palsies, papilledema, and
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FIGURE 1 |There is diffuse smooth enhancement of the
pachymeninges (A), left greater than right, with apparent
thickening (B). Globes are normal in their size, shape, and signal intensity
on all pulse sequences. No evidence of intra or extraconal soft tissue mass.
Bilateral enhancement of posterior intraconal optic nerve sheath with
normal signal intensity of optic nerves.
FIGURE 2 | Hematoxylin and eosin (H&E) stain at high power (A) and
low power (B) demonstrate dural thickening with prominent
lymphoplasmacytic infiltrate. On high power (A), the infiltrate is
composed of mostly plasma cells. Immunohistochemical stain for IgG
(C) and IgG4 (D) demonstrate that most of the plasma cells are positive for
IgG and that the vast majority of the plasma cells are IgG4 positive.
unilateral or bilateral visual loss (1, 2, 4, 5). These presentations can
also be included as those of IgG4-RD. The visual loss associated
with HP has been attributed to inflammatory optic neuropathy.
Other potential mechanisms of visual loss include infiltrative and
compressive retrobulbar optic neuropathy (6, 7).
CONCLUSION
We describe a patient with visual loss due to pachymeningitis from
IgG4-RD. We believe that a proportion of IHP actually represents
IgG4-RD and that clinicians should consider testing for this condi-
tion with biopsy and IgG4 immunostaining. Establishing a diag-
nosis of IgG4-RD is important in planning immunosuppressive
therapy to prevent future complications.
TEACHING POINTS
Consider IgG4-RD in the differential diagnosis of HP. Definitive
diagnosis of IgG4-RD requires biopsy demonstrating characteris-
tic histopathology along with IgG4 immunostaining. Initial out-
come is favorable with corticosteroids, though response is often
unsustained in the long-term, thus, additional immunosuppres-
sive agents may be required. Patients with single organ involve-
ment of IgG4-RD should be followed and screened for systemic
involvement as disease may develop in multiple locations.
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